Evidence map›Paper›PMID 33731872›Full record

ReviewNature reviews. Rheumatology2021

Biological classification of childhood arthritis: roadmap to a molecular nomenclature.

Peter A Nigrovic, Robert A Colbert, V Michael Holers, Seza Ozen, Nicolino Ruperto, Susan D Thompson, Lucy R Wedderburn, Rae S M Yeung, Alberto Martini

Erratum issuedAbstract readReview
In one paragraph

Review in Nature reviews. Rheumatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Trial
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Peter A NigrovicDivision of Immunology, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA. peter.nigrovic@childrens.harvard.edu.
Robert A ColbertPediatric Translational Research Branch, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
V Michael HolersDivision of Rheumatology, Departments of Medicine and Immunology, University of Colorado School of Medicine, Aurora, CO, USA.
Seza OzenDivision of Rheumatology, Department of Pediatrics, Hacettepe University, Ankara, Turkey.ORCID http://orcid.org/0000-0003-2883-7868
Nicolino RupertoIRCCS Istituto Giannina Gaslini, Genova, Italy.ORCID http://orcid.org/0000-0001-8407-7782
Susan D ThompsonCenter for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0003-4130-2796
Lucy R WedderburnInfection, Inflammation and Rheumatology, UCL Great Ormond Street Institute of Child Health, London, UK.ORCID http://orcid.org/0000-0002-7495-1429
Rae S M YeungDepartments of Paediatrics, Immunology and Medical Sciences, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0003-2361-725X
Alberto MartiniIRCCS Istituto Giannina Gaslini, Genova, Italy. albertomartini@gaslini.org.ORCID http://orcid.org/0000-0001-7642-1459

Funding

Clinical Support Services for the NIAMS Intramural Research ProgramZIDAR041180 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$119.2M
Pathogenic Mechanisms in SpondyloarthritisZIAAR041184 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$47.6M
Joint Biology Consortium Resource-based CenterP30AR070253 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic, Jeffrey Andrew Sparks · 2016 to 2026
$9.4M
Tissue Acquisition Research GroupUM2AR067678 · NIAMS · STANFORD UNIVERSITY · PI HOLERS, VERNON MICHAEL, UTZ, PAUL JOSEPH · 2014 to 2020
$8.2M
Tissue Repository CoreP30AR070549 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Leah Claire Kottyan · 2016 to 2026
$7.7M
Gene Regulation as a Foundation for Autoimmune Disease PreventionU01AI130830 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI WEIRAUCH, MATTHEW TYSON · 2017 to 2021
$7.2M
Complement in the Pathogenesis of Autoimmune ArthritisR01AR051749 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI Vernon Michael Holers · 2004 to 2026
$6.7M
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid ArthritisU01AI101981 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 2012 to 2021
$6.2M
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established DiseaseUH2AR067681 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 2014 to 2020
$5.5M
Colorado REACH HubU01HL152405 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DUKE, RICHARD C · 2019 to 2022
$5.1M
Ly6 family members in neutrophil biologyR01AR065538 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI NIGROVIC, PETER A · 2014 to 2024
$4.0M
Predicting uveitis onset in children with juvenile idiopathic arthritisR01EY030521 · NEI · CINCINNATI CHILDRENS HOSP MED CTR · PI ANGELES-HAN, SHEILA THERESE · 2019 to 2023
$3.2M
Department of HealthMedical Research Council MR/M004600/1Medical Research Council MR/R013926/1NEI NIH HHS R01 EY030521NHLBI NIH HHS R21 HL150575NHLBI NIH HHS U01 HL152405NIAID NIH HHS U01 AI101981NIAID NIH HHS U01 AI130830NIAMS NIH HHS P30 AR070253NIAMS NIH HHS P30 AR070549NIAMS NIH HHS R01 AR051749NIAMS NIH HHS R01 AR065538NIAMS NIH HHS R01 AR073201NIAMS NIH HHS R01 AR075906NIAMS NIH HHS R21 AR076630NIAMS NIH HHS UH2 AR067681NIAMS NIH HHS UM2 AR067678NICHD NIH HHS R01 HD089928NIDDK NIH HHS R01 DK125823Versus Arthritis 21593Versus Arthritis 22084
6 · The paper itself

Abstract

Chronic inflammatory arthritis in childhood is heterogeneous in presentation and course. Most forms exhibit clinical and genetic similarity to arthritis of adult onset, although at least one phenotype might be restricted to children. Nevertheless, paediatric and adult rheumatologists have historically addressed disease classification separately, yielding a juvenile idiopathic arthritis (JIA) nomenclature that exhibits no terminological overlap with adult-onset arthritis. Accumulating clinical, genetic and mechanistic data reveal the critical limitations of this strategy, necessitating a new approach to defining biological categories within JIA. In this Review, we provide an overview of the current evidence for biological subgroups of arthritis in children, delineate forms that seem contiguous with adult-onset arthritis, and consider integrative genetic and bioinformatic strategies to identify discrete entities within inflammatory arthritis across all ages.

Indexed as

Polymorphism, Single NucleotideTerminology as TopicArthritis, JuvenileChildComputational BiologyHumansPhenotype

Identifiers

PMID33731872
PMCPMC10355214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.